Moderna (MRNA)’s Melanoma Vaccine Win: Big Opportunity, Bigger Expectations
Intismeran, Moderna’s personalized mRNA melanoma vaccine, met its main goal of reducing melanoma recurrence and also showed benefit in preventing the cancer from spreading when used with Merck’s Keytruda.
Aug 19, 2026 ·
Yahoo Finance



















